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ABSTRACT
Recent guidelines for the management of asthma recom-
mend that peak expiratory flow (PEF) should be measured
to monitor the level of airflow limitation and to maintain
PEF values within the green zone (80–100% of the
patient’s highest PEF value). Because no studies have
evaluated the efficacy of PEF zone management on the
basis of patients’ physical activity, we studied the appear-
ance of exercise-induced asthma (EIA) using treadmill
exercise challenging in asthma patients whose PEF values
had been maintained in the green zone for at least 3
months. Exercise-induced asthma was induced in nine of
44 (20.5%) asthma patients. The acetylcholine concen-
tration required to cause a 20% fall in forced expiratory
volume in 1 s (log PC20) was significantly lower in patients
with EIA (2.39 ± 0.21 m g/mL) compared with patients
without EIA (3.22 ± 0.12 m g/mL; P < 0.03). These
results suggest that PEF green zone management alone
does not ensure the ability to perform vigorous physical
activity, especially in patients whose airway reactivity
remains enhanced. Therefore, airway reactivity should be
considered for asthma management.
Key words: airway hyperreactivity, exercise-induced
asthma, green zone, peak expiratory flow.
INTRODUCTION
Exercise-induced asthma (EIA) occurs in 40 to 90% of
patients with asthma not treated with steroids.1 Because
EIA is an early manifestation of asthma and is associated
with enhanced airway reactivity, exercise challenge is a
useful method for diagnosing asthma. Furthermore, the
presence of EIA suggests a lack of control of asthma and
appropriate treatment can prevent EIA.2 Recent guidelines
for asthma treatment recommend a system in which peak
expiratory flow (PEF) values are divided into three zones: a
green zone of 80 to 100% of the patient’s highest PEF
value, a yellow zone of 60 to 80% and a red zone of less
than 60%. The goal of treatment is to maintain PEF values
within the green zone. An additional goal of treatment is to
control the symptoms of asthma without limiting vigorous
physical activity, including exercise.3 Therefore, in the
present study, we performed a treadmill exercise challenge
test in asthma patients whose PEF was within the green
zone to evaluate the efficacy of the asthma zone manage-
ment system for allowing physical activity.
METHODS
Fifty asthma patients whose PEF values had been in the
green zone for at least 3 months and ten normal volun-
teers were enrolled. At the time of enrolment, none of the
subjects had had upper respiratory tract infections in the
previous 6 weeks. Thirteen asthma patients were being
treated with bronchodilators (slow-release theophylline,
inhaled b 2-adrenoreceptor agonists as required, or both)
and 37 patients were being treated with bronchodilators
and inhaled glucocorticosteroids (beclomethasone dipro-
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pionate, BDP; 400–1200 m g/day). The patients’ morning,
daytime and evening PEF were confirmed to be in the
green zone on the basis of their highest values as meas-
ured with a Mini-light peak flowmeter (Clement Clark
International Ltd, Harlow, UK). No patients had received
oral steroids in the previous 12 weeks.
All patients underwent blood tests and evaluation of
airway reactivity to acetylcholine (ACh). Within 2 weeks,
the treadmill exercise challenge test was performed and
respiratory function was measured by spirometry before
and after exercise challenge. All examinations were per-
formed at approximately the same time each day by the
same investigators. All bronchodilators were withheld for
at least 12 h and inhaled glucocorticosteroids were with-
held for at least 24 h before examinations. Plasma
concentrations of theophylline in subjects receiving this
drug were measured before ACh and exercise challenges
and were confirmed to be less than 5 m g/mL. Informed
consent was obtained before the start of the study.
Airway reactivity to ACh was measured. Briefly, after
inhalation of normal saline, dilutions of ACh, doubling 
in concentration, were inhaled with the Devilbiss 646 
nebulizer (Somerset, PA, USA) operated with 5 L/min
compressed air for 2 min by tidal breathing until forced
expiratory volume in 1 s (FEV1) had decreased by more
than 20% of the baseline value. Results are expressed as
the provocative concentration causing a 20% decrease in
FEV1 (PC20).
The exercise test consisted of steady-state running for
6 min on a treadmill inclined to produce a heart rate of at
least 85% of the maximum predicted for age (calculated
as 220 – age).4 In a preliminary study, we found that
running at 100 m/min on a treadmill inclined 10° would
produce the desired heart rate in normal adult subjects.
The exercise test was performed when room temperature
ranged from 25 to 26°C and humidity ranged from 59 to
62%. After FEV1 had been confirmed to be at least 70%
of the predicted value in patients with asthma and normal
volunteers, exercise challenge was performed and FEV1
was measured 1, 5, 10, 15 and 30 min after the end of
exercise. Plasma concentrations of potassium and lactic
acid in whole blood were measured before and after
exercise challenge. The diagnosis of EIA was confirmed
by a recorded fall in FEV1 of 15% or more from the base-
line value.5,6
The Mann–Whitney U-test was used for statistical analy-
sis. Data for PC20 were expressed as geometric means with
the geometric standard error of the mean (GSEM), and
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Table 1
Results are expressed as the means ± SEM for patients with (+) and without (–) exercise-induced asthma (EIA) and for normal subjects. Maximum
heart rate (HR) and maximum percent decrease in forced expiratory volume in 1 s (FEV1) are shown as percentages after exercise. PEF, peak expira-
tory flow; FVC, forced vital capacity; V˙50, V˙25, maximum expiratory flow at 50 and 25%, respectively, of FVC; PC20, concentration of acetylcholine
required to decrease FEV1 by 20%.
Patients Normal subjects
EIA (+) EIA (–)
n 9 35 10
Age (years) 30.7 ± 4.1 30.9 ± 1.4 38.6 ± 3.5
Sex (M/F) 5/4 18/17 4/6
Duration of asthma (years) 15.0 ± 2.8 9.0 ± 1.6
IgE (U/mL) 546 ± 216 406 ± 93 38.8 ± 18.8
Eosinophils (cells /m L) 379 ± 95 397 ± 155 118 ± 42
Log PC20 (m g/mL) 2.39 ± 0.21 3.22 ± 0.12
Pre-exercise
FVC (% of predicted) 106.5 ± 7.6 106.8 ± 2.7 107.3 ± 4.0
FEV1 (% of predicted) 77.5 ± 2.3 79.7 ± 1.3 86.7 ± 1.9
FEV1% 74.1 ± 1.4 76.4 ± 1.3 85.6 ± 2.3
V˙50 2.99 ± 0.31 3.34 ± 0.18 4.20 ± 0.33
V˙25 1.28 ± 0.18 1.48 ± 0.09 1.83 ± 0.14
PEF (% by best values) 90.8 ± 2.9 91.5 ± 2.0 97.0 ± 2.1
Exercise challenge
Maximum HR (%) 93.5 ± 3.9 92.9 ± 2.1 97.7 ± 6.2
Maximum decrease in FEV1 (%) 28.5 ± 3.6 2.23 ± 0.50 1.71 ± 1.01
Increase in potassium (mEq/L) 0.81 ± 0.21 0.91 ± 0.06 0.93 ± 0.14
Increase in lactate (mmol/L) 5.64 ± 0.59 5.41 ± 3.18 6.54 ± 0.62
other data are expressed as mean ± standard error of the
mean (SEM). Differences with P < 0.05 were considered
significant.
RESULTS
Forty-four asthma patients completed the trial but six
patients, three treated with bronchodilators and three
treated with both bronchodilators and inhaled glucocortico-
steroids, dropped out because of an increase in blood
pressure or general fatigue during exercise. Characteristics
of subjects who completed the study are shown in Table 1.
After treadmill exercise, peak heart rates in all subjects
exceeded 85% of the maximal rates for their ages. Blood
analysis revealed no significant differences in increases in
potassium and lactic acid between asthma patients with
and without EIA, and normal subjects (Table 1). Therefore,
a similar intensity of exercise was induced in all subjects.
Maximal decreases in FEV1 after exercise are shown in
Table 1. Exercise-induced asthma was induced in nine of
44 (20.5%) asthma patients; four patients were being
treated with bronchodilators alone and five were being
treated with inhaled glucocorticosteroids and bron-
chodilators. No significant decreases in FEV1 were
observed in normal subjects. The log PC20 was signifi-
cantly lower in patients with EIA (2.39 ± 0.21 m g/mL)
than in patients without EIA (3.22 ± 0.12 m g/mL;
P < 0.01; Fig. 1). The log PC20 values of the patients with
EIA who were treated with bronchodilators or bron-
chodilators and inhaled glucocorticosteroids were
2.29 ± 0.17 m g/mL (n = 4) and 2.46 ± 0.36 m g/mL 
(n = 5), respectively. The log PC20 values of the patients
without EIA who were treated with bronchodilators or
bronchodilators and inhaled glucocorticosteroids were
2.64 ± 0.28 m g/mL (n = 6) and 3.34 ± 0.11 m g/mL
(n = 29), respectively. There was no significant relation-
ship between airway reactivity to ACh (PC20) and FEV1,
maximum expiratory flow at 50% and 25% of forced vital
capacity (V˙50 and V˙25, respectively) or PEF variability in
patients with EIA (data not shown).
DISCUSSION
Recent guidelines for the management of asthma recom-
mend that PEF should be measured to monitor the level
of airflow limitation; PEF can even be measured by
patients themselves.3 However, to our knowledge, no
studies have evaluated the efficacy of PEF zone manage-
ment on the basis of patients’ physical activity. Therefore,
we studied the appearance of EIA by treadmill exercise
challenge in asthma patients whose PEF values had been
maintained in the green zone for at least 3 months.
We found that 20.5% of asthma patients with PEF
values in the green zone experienced EIA on treadmill
exercise challenge. There are several possible explana-
tions for the high incidence of EIA in these asthma
patients. First, PEF was confirmed to be in the green zone
on the basis of measurements at rest, but not after exer-
cise. Second, patients performed exercise at maximal
levels. Third, bronchodilators used by patients were with-
held before exercise. However, because all guidelines for
asthma recommend that normal activity levels, including
exercise, should be maintained, but do not specify exer-
cise levels, we presented patients with an exercise
challenge to produce a heart rate of at least 85% of the
maximum predicted for age.
Our finding that EIA was induced, despite treatment
with inhaled glucocorticosteroids, in five of 37 patients
in whom asthma was controlled in the green zone sup-
ports the findings of a previous study in which EIA
occurred in asthma patients with normal lung function
who were receiving inhaled glucocorticosteroids.7
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Fig. 1 Airway reactivity to acetylcholine in asthma patients
with (+) and without (–) exercise-induced asthma (EIA) whose
peak expiratory flow values were in the green zone. The hori-
zontal bar shows the geometric mean value of PC20 (log PC20).
Log PC20 in patients with EIA and without EIA was 2.39 ± 0.21
and 3.22 ± 0.12 m g/mL, respectively.
Because decrease in FEV1 after exercise is reported to
correlate with airway hyperreactivity,8 we compared
airway reactivity between patients with and without EIA.
We found that airway reactivity to ACh was higher in
patients with EIA than in patients without EIA. However,
the fact that EIA was not induced in some patients with
asthma whose airway reactivity to ACh was enhanced
suggests that EIA was not only associated with the degree
of airway reactivity. Furthermore, we also found that EIA
was not associated with baseline respiratory function
including FEV1, V˙50, V˙25 and PEF variability. These results
suggest that the induction of EIA is not merely regulated
by the dilation of central and peripheral airways.
Correlation between airway reactivity to exercise and
methacholine has been studied but the results were con-
troversial.9–11 One study showed a significant correlation
between airway reactivity to methacholine and exercise9
but another failed to demonstrate the significant relation-
ship, especially in asthma children who were treated with
inhaled glucocorticosteroids.10 Although airway reactivity
to ACh in patients with EIA was significantly enhanced
compared with patients without EIA in the present study,
there was no significant correlation between decreases 
in FEV1 and PC20. Therefore, the association between
airway reactivity to exercise and ACh seems to be
complex in patients with asthma.
The asthma guidelines of the National Heart, Lung and
Blood Institute (NHLBI) distinguished EIA from sponta-
neous asthma symptoms.3 Exercise-induced asthma is not
a determining factor for the classification of persistent
asthma. Exercise-induced asthma is appropriately man-
aged with pretreatment with inhaled b -adrenoreceptor
agonists and, if necessary, cromolyn.12 Therefore EIA, by
itself, is not an indication for long-term control medication.
Although the presence of EIA after treadmill challenge in
some patients with asthma whose PEF readings are within
the green zone would not be an indication for more 
intensive anti-inflammatory treatment, use of inhaled 
b -adrenoreceptor agonist and/or cromolyn should be 
recommended for these patients before exercise.
We conclude that PEF green zone management alone
does not ensure the ability to perform vigorous physical
activity, especially in patients whose airway reactivity
remains enhanced. Therefore, airway reactivity should
be considered for asthma management and exercise
challenge is a useful method for evaluating the efficacy
of treatment aimed at allowing vigorous physical activity.
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